BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29587717)

  • 1. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.
    Hammoudeh S; Ghuloum S; Mahfoud Z; Yehya A; Abdulhakam A; Al-Mujalli A; Al-Zirie M; Abdel Rahman MO; Godwin A; Younes N; Hani Y; Mook-Kanamori D; Mook-Kanamori M; El Sherbiny R; Al-Amin H
    BMC Psychiatry; 2018 Mar; 18(1):81. PubMed ID: 29587717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication.
    Morell R; Curtis J; Watkins A; Poole J; Fibbins H; Rossimel E; Gerrard M; White A; Teasdale S; Ward PB; Lappin J
    Psychiatry Res; 2019 Nov; 281():112606. PubMed ID: 31629301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study.
    Syed MA; Al Nuaimi AS; Latif Zainel AJA; A/Qotba HA
    BMC Public Health; 2020 May; 20(1):611. PubMed ID: 32362284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.
    Devlin AM; Ngai YF; Ronsley R; Panagiotopoulos C
    Transl Psychiatry; 2012 Jan; 2(1):e71. PubMed ID: 22832733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
    Saloojee S; Burns JK; Motala AA
    PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study.
    Hammoudeh S; Al Lawati H; Ghuloum S; Iram H; Yehya A; Becetti I; Al-Fakhri N; Ghabrash H; Shehata M; Ajmal N; Amro I; Safdar H; Eltorki Y; Al-Amin H
    Community Ment Health J; 2020 May; 56(4):760-770. PubMed ID: 31884574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
    Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.
    Sicras-Mainar A; Blanca-Tamayo M; Rejas-Gutiérrez J; Navarro-Artieda R
    Eur Psychiatry; 2008 Mar; 23(2):100-8. PubMed ID: 17904825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study.
    Jiang B; Zheng Y; Chen Y; Chen Y; Li Q; Zhu C; Wang N; Han B; Zhai H; Lin D; Lu Y
    Lipids Health Dis; 2018 Apr; 17(1):92. PubMed ID: 29678174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders.
    Abdel Aziz K; Mohd Ahmed H; Stip E; Aly El-Gabry D
    Int Clin Psychopharmacol; 2024 Jul; 39(4):257-266. PubMed ID: 38381917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.
    Severi E; Ferrara M; Tedeschini E; Vacca F; Mungai F; Amendolara R; Baccari F; Starace F
    Int J Ment Health Nurs; 2018 Jun; 27(3):1002-1008. PubMed ID: 29197134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey.
    Al-Thani MH; Al-Thani AA; Cheema S; Sheikh J; Mamtani R; Lowenfels AB; Al-Chetachi WF; Almalki BA; Hassan Khalifa SA; Haj Bakri AO; Maisonneuve P
    BMJ Open; 2016 Sep; 6(9):e009514. PubMed ID: 27601485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Tadewos A; Egeno T; Amsalu A
    BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.